Goldenwell Biotech Stock Probability of Future Pink Sheet Price Finishing Over 1.95
| GWLL Stock | USD 1.95 0.06 2.99% |
Goldenwell |
Goldenwell Biotech Target Price Odds to finish over 1.95
The tendency of Goldenwell Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.95 | 90 days | 1.95 | about 72.39 |
Based on a normal probability distribution, the odds of Goldenwell Biotech to move above the current price in 90 days from now is about 72.39 (This Goldenwell Biotech probability density function shows the probability of Goldenwell Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 11.76 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Goldenwell Biotech will likely underperform. In addition to that Goldenwell Biotech has an alpha of 10.9858, implying that it can generate a 10.99 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Goldenwell Biotech Price Density |
| Price |
Predictive Modules for Goldenwell Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Goldenwell Biotech. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Goldenwell Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Goldenwell Biotech is not an exception. The market had few large corrections towards the Goldenwell Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Goldenwell Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Goldenwell Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 10.99 | |
β | Beta against Dow Jones | 11.76 | |
σ | Overall volatility | 1.43 | |
Ir | Information ratio | 0.15 |
Goldenwell Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Goldenwell Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Goldenwell Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Goldenwell Biotech is way too risky over 90 days horizon | |
| Goldenwell Biotech may become a speculative penny stock | |
| Goldenwell Biotech appears to be risky and price may revert if volatility continues | |
| Goldenwell Biotech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 18.97 K. Net Loss for the year was (107.48 K) with profit before overhead, payroll, taxes, and interest of 8.39 K. | |
| Goldenwell Biotech currently holds about 42.86 K in cash with (202.57 K) of positive cash flow from operations. | |
| Roughly 63.0% of the company shares are held by company insiders |
Goldenwell Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Goldenwell Pink Sheet often depends not only on the future outlook of the current and potential Goldenwell Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Goldenwell Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Float Shares | 36M | |
| Average Daily Volume In Three Month | 750 |
Goldenwell Biotech Technical Analysis
Goldenwell Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Goldenwell Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Goldenwell Biotech. In general, you should focus on analyzing Goldenwell Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Goldenwell Biotech Predictive Forecast Models
Goldenwell Biotech's time-series forecasting models is one of many Goldenwell Biotech's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Goldenwell Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Goldenwell Biotech
Checking the ongoing alerts about Goldenwell Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Goldenwell Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Goldenwell Biotech is way too risky over 90 days horizon | |
| Goldenwell Biotech may become a speculative penny stock | |
| Goldenwell Biotech appears to be risky and price may revert if volatility continues | |
| Goldenwell Biotech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 18.97 K. Net Loss for the year was (107.48 K) with profit before overhead, payroll, taxes, and interest of 8.39 K. | |
| Goldenwell Biotech currently holds about 42.86 K in cash with (202.57 K) of positive cash flow from operations. | |
| Roughly 63.0% of the company shares are held by company insiders |
Other Information on Investing in Goldenwell Pink Sheet
Goldenwell Biotech financial ratios help investors to determine whether Goldenwell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goldenwell with respect to the benefits of owning Goldenwell Biotech security.